| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/12/2000 | US6117875 Prophylactic or therapeutic treatment of phosphodiesterase iv (pde-iv) and tumor necrosis factor (tnf) mediated diseases |
| 09/12/2000 | US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists |
| 09/12/2000 | US6117873 Can be used for the treatment of pathological conditions which respond to blockage of excitatory amino acid receptors |
| 09/12/2000 | US6117868 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/12/2000 | US6117862 Model and method for angiogenesis inhibition |
| 09/12/2000 | US6117861 Protein kinase C inhibitor |
| 09/12/2000 | US6117839 For increasing bone growth in mammals |
| 09/12/2000 | US6117450 Selecting a predetermined number of at least three of four compressed compositions containing an effective ingredient or combination defined by their release |
| 09/12/2000 | US6117430 Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/08/2000 | WO2000052210A2 Methods for targeting rna molecules |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000052057A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 09/08/2000 | WO2000052032A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052021A1 Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs |
| 09/08/2000 | WO2000052020A1 Novel sulforhamnosylacylglycerol derivatives and utilization thereof as drugs |
| 09/08/2000 | WO2000051998A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | WO2000051985A1 Fluorides of 4-substituted piperidine derivatives |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051968A1 Method for the preparation of a chiral-beta-amino ester |
| 09/08/2000 | WO2000051686A1 Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
| 09/08/2000 | WO2000051622A1 Drugs containing sulfopyranosylacylglycerol derivatives |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051605A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
| 09/08/2000 | WO2000051604A1 Intermittent claudication remedies |
| 09/08/2000 | WO2000051562A1 Matrix metalloprotease inhibitor and utilization thereof |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051546A2 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | WO2000051428A1 Compositions for aquatic contained in a microparticulate or nanoparticulate vector |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000035407A3 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000027341A3 Novel method of treatment |
| 09/08/2000 | WO2000020026A3 Compositions and methods for inhibiting angiogenesis |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000010526A3 New oral formulation for 5-ht4 agonists or antagonists |
| 09/08/2000 | WO2000009709A3 Proteases and associated proteins |
| 09/08/2000 | WO2000000604A9 Methods and compositions for modulating spermatogenesis |
| 09/08/2000 | WO1999034784A3 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 09/08/2000 | CA2373463A1 Intermittent claudication remedies |
| 09/08/2000 | CA2363961A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2363077A1 Methods for targeting rna molecules |
| 09/08/2000 | CA2362911A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362361A1 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | CA2360740A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033129A1 Antimicrobials |
| 09/06/2000 | EP1032697A1 High efficiency retroviral vectors that contain none of viral coding sequences |
| 09/06/2000 | EP1032671A1 Mammalian cytokine-like polypeptide-10 |
| 09/06/2000 | EP1032670A1 Toso |
| 09/06/2000 | EP1032664A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 09/06/2000 | EP1032656A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 09/06/2000 | EP1032579A1 Carbohydrate derivatives |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032569A1 Imidazole derivatives, preparation and therapeutic application thereof |
| 09/06/2000 | EP1032562A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 09/06/2000 | EP1032561A1 Substituted oximes as neurokinin antagonists |
| 09/06/2000 | EP1032427A2 Conjugates of cytokines and drugs or genes for treating proliferating cells |
| 09/06/2000 | EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032415A2 Composition for the treatment of allergic conditions having cysteine and serine proteinase inhibitory activity |
| 09/06/2000 | EP1032414A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 09/06/2000 | EP1032413A1 Chemoprotective bacterial strains |
| 09/06/2000 | EP1032412A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 09/06/2000 | EP1032409A1 Herbal extract composition and method with immune-boosting capability |
| 09/06/2000 | EP1032403A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 09/06/2000 | EP1032401A2 Method for inhibiting cytokine production by cells |
| 09/06/2000 | EP1032397A1 Testosterone inhibitors and use for the protection of neurons |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032388A1 Novel metal complexes |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032386A1 Use of oxazolidinone derivatitives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032381A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 09/06/2000 | EP1032265A1 New psoralens for pathogen inactivation |
| 09/06/2000 | EP0792149B1 Oral compositions containing ondansetron |
| 09/06/2000 | EP0770089B1 Growth differentiation factor-12 |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0590015B1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
| 09/06/2000 | CN1265741A Method and compositions for overcoming resistance to biologic and chemotherapy |
| 09/06/2000 | CN1265675A Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265672A Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265668A Subtsituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265649A Indole derivatives as MCP-1 receptor antagonists |
| 09/06/2000 | CN1265648A Conjugaes of dithiocarbamates with pharmacologically active agents and uses therefor |